GLPwatch

Ozempic vs Wegovy

Drug comparison

Last updated 2026-05-28 15:46 UTC

Ozempic and Wegovy both contain the same active ingredient, semaglutide, and are made by Novo Nordisk, but they are FDA-approved for different uses: Ozempic treats type 2 diabetes and reduces cardiovascular risk and chronic kidney disease, while Wegovy is approved for obesity and also reduces cardiovascular risk. Both are given as injections under the skin, but they are not interchangeable—Ozempic is prescribed for diabetes, and Wegovy is prescribed for weight management.

AI summary of the sources below.

Ozempic Wegovy
Active ingredientsemaglutidesemaglutide
Manufacturernovo-nordisknovo-nordisk
Routesubcutaneous injectionsubcutaneous injection
FDA-approved fortype 2 diabetes, cardiovascular risk reduction, chronic kidney diseaseobesity, cardiovascular risk reduction
Label updated2026-01-302026-05-05

Compare full details on the Ozempic and Wegovy pages.